Editas Medicine Inc. logo

Editas Medicine Inc. (EDIT)

Market Closed
11 Aug, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
2. 95
+0.14
+4.9822%
$
271.18M Market Cap
- P/E Ratio
- Div Yield
1.9M Volume
-2.37 Eps
$ 2.81
Previous Close
Analysts:
Add Transaction
Day Range
2.83 2.98
Year Range
1.66 4.54
Want to track EDIT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Editas Medicine Inc. (EDIT) Statistics

Valuation metrics

Market Cap 271.18M
Enterprise value 275.67M
Trailing P/E (ttm) -3.85
Forward P/E -3.05
PEG ratio -0.02
Price/Sales (ttm) 9.4
Price/Book (mrq) 3.26
Enterprise Value/Revenue 5.86
Enterprise Value/EBITDA -3.93

Overview

Shares outstanding 97.9M
Float 97.64M
Shares short 10.01M
% Held by insiders 0%
% Held by institutions 0.55%
Average volume (10 days) 1.62M
Average volume (90 days) 1.83M

Price summary

52-Week low 1.66
52-Week high 4.54
Beta 2.14
50-Day moving average 2.82
200-Day moving average 2.54

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026

Profitability

Profit margin -1.57%
Operating margin -1.75%

Operational effectiveness

Return on assets -0.31%
Return on equity -1.97%

Income Statement

Revenue (ttm) 38.69M
Revenue per share (ttm) 0.39
Quarterly revenue growth (yoy) -0.39%
Gross profit (ttm) -42.27M
EBITDA -85.19M
Net income to common (ttm) -108.95M
Diluted EPS (ttm) -0.62
Quarterly earnings growth (yoy) -0.39%

Balance Sheet

Total cash (mrq) 123.65M
Total cash per share (mrq) 1.77
Total debt (mrq) 17.3M
Total Debt/Equity (mrq) 0.15
Current ratio (mrq) 3.19%
Book value per share (mrq) 0.88

Cash Flow

Cash flow statement -140.5M
Levered free cash flow (LFCF) -73.82M